206 related articles for article (PubMed ID: 17549301)
1. Biphasic effect of pioglitazone on isolated human endothelial progenitor cells: involvement of peroxisome proliferator-activated receptor-gamma and transforming growth factor-beta1.
Redondo S; Hristov M; Gümbel D; Tejerina T; Weber C
Thromb Haemost; 2007 Jun; 97(6):979-87. PubMed ID: 17549301
[TBL] [Abstract][Full Text] [Related]
2. PPAR-γ agonist pioglitazone prevents apoptosis of endothelial progenitor cells from rat bone marrow.
Zhang HF; Wang L; Yuan HJ; Ma YH; Wang YF; Hu ZY; Su Y; Zhao ZG
Cell Biol Int; 2013 May; 37(5):430-5. PubMed ID: 23504801
[TBL] [Abstract][Full Text] [Related]
3. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance.
Werner C; Kamani CH; Gensch C; Böhm M; Laufs U
Diabetes; 2007 Oct; 56(10):2609-15. PubMed ID: 17623816
[TBL] [Abstract][Full Text] [Related]
4. The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells.
Gensch C; Clever YP; Werner C; Hanhoun M; Böhm M; Laufs U
Atherosclerosis; 2007 May; 192(1):67-74. PubMed ID: 16876172
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone induces apoptosis in human vascular smooth muscle cells from diabetic patients involving the transforming growth factor-beta/activin receptor-like kinase-4/5/7/Smad2 signaling pathway.
Ruiz E; Redondo S; Gordillo-Moscoso A; Tejerina T
J Pharmacol Exp Ther; 2007 May; 321(2):431-8. PubMed ID: 17267584
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone induces vascular smooth muscle cell apoptosis through a peroxisome proliferator-activated receptor-gamma, transforming growth factor-beta1, and a Smad2-dependent mechanism.
Redondo S; Ruiz E; Santos-Gallego CG; Padilla E; Tejerina T
Diabetes; 2005 Mar; 54(3):811-7. PubMed ID: 15734860
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products.
Liang C; Ren Y; Tan H; He Z; Jiang Q; Wu J; Zhen Y; Fan M; Wu Z
Br J Pharmacol; 2009 Dec; 158(8):1865-73. PubMed ID: 19917066
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts.
Zafiriou S; Stanners SR; Saad S; Polhill TS; Poronnik P; Pollock CA
J Am Soc Nephrol; 2005 Mar; 16(3):638-45. PubMed ID: 15689403
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1 modulates extracellular matrix production, proliferation, and apoptosis of endothelial progenitor cells in tissue-engineering scaffolds.
Sales VL; Engelmayr GC; Mettler BA; Johnson JA; Sacks MS; Mayer JE
Circulation; 2006 Jul; 114(1 Suppl):I193-9. PubMed ID: 16820571
[TBL] [Abstract][Full Text] [Related]
11. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway.
Nuwormegbe SA; Sohn JH; Kim SW
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722
[TBL] [Abstract][Full Text] [Related]
12. Serum derived from multiple trauma patients promotes the differentiation of endothelial progenitor cells in vitro: possible role of transforming growth factor-beta1 and vascular endothelial growth factor165.
Henrich D; Hahn P; Wahl M; Wilhelm K; Dernbach E; Dimmeler S; Marzi I
Shock; 2004 Jan; 21(1):13-6. PubMed ID: 14676678
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models.
Gu J; Liu X; Wang QX; Guo M; Liu F; Song ZP; Zhang DD
J Mol Cell Cardiol; 2013 Dec; 65():1-8. PubMed ID: 24100253
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus.
Wang CH; Ting MK; Verma S; Kuo LT; Yang NI; Hsieh IC; Wang SY; Hung A; Cherng WJ
Am Heart J; 2006 Dec; 152(6):1051.e1-8. PubMed ID: 17161050
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells.
Ohama Y; Harada T; Iwabe T; Taniguchi F; Takenaka Y; Terakawa N
Fertil Steril; 2008 Feb; 89(2):311-7. PubMed ID: 17555752
[TBL] [Abstract][Full Text] [Related]
17. PPAR-γ agonist pioglitazone regulates dendritic cells immunogenicity mediated by DC-SIGN via the MAPK and NF-κB pathways.
Zhu W; Yan H; Li S; Nie W; Fan F; Zhu J
Int Immunopharmacol; 2016 Dec; 41():24-34. PubMed ID: 27792919
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone improves in vitro viability and function of endothelial progenitor cells from individuals with impaired glucose tolerance.
Spigoni V; Picconi A; Cito M; Ridolfi V; Bonomini S; Casali C; Zavaroni I; Gnudi L; Metra M; Dei Cas A
PLoS One; 2012; 7(11):e48283. PubMed ID: 23139771
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition-like phenotypic changes of retinal pigment epithelium induced by TGF-β are prevented by PPAR-γ agonists.
Hatanaka H; Koizumi N; Okumura N; Kay EP; Mizuhara E; Hamuro J; Kinoshita S
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6955-63. PubMed ID: 22956604
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis.
Werner C; Gensch C; Pöss J; Haendeler J; Böhm M; Laufs U
Atherosclerosis; 2011 May; 216(1):23-34. PubMed ID: 21396644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
